Daiichi Sankyo Pharma Development recalls Benicar HCT Tablets (olmesartan medoxomil, hydrochlorothiazide) 20 mg/12.5 mg, 30 count bottles, Rx Only, Manufactured f
Recalled August 6, 2014 · FDA recall D-1503-2014 · Daiichi Sankyo Pharma Development
Hazard
Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping · FDA Class II
Units
108 bottles
Sold at
Nationwide
Description
Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping
Product
Benicar HCT Tablets (olmesartan medoxomil, hydrochlorothiazide) 20 mg/12.5 mg, 30 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 --- NDC 65597-105-30
Manufacturer(s)
Daiichi Sankyo Pharma Development
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →